These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24913933)

  • 1. Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy.
    Tawdy MH; Abd El Nasser MM; Abd El Shafy SS; Nada MA; El Sirafy MN; Magd AH
    J Clin Neurosci; 2014 Sep; 21(9):1606-11. PubMed ID: 24913933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The involvement of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in atherosclerosis.
    Michowitz Y; Goldstein E; Roth A; Afek A; Abashidze A; Ben Gal Y; Keren G; George J
    J Am Coll Cardiol; 2005 Apr; 45(7):1018-24. PubMed ID: 15808757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL mRNA expression in peripheral blood mononuclear cells of Egyptian SLE patients.
    El-Karaksy SM; Kholoussi NM; Shahin RM; El-Ghar MM; Gheith Rel-S
    Gene; 2013 Sep; 527(1):211-4. PubMed ID: 23792015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.
    Tanaka H; Ito T; Kyo T; Kimura A
    Eur J Haematol; 2007 May; 78(5):389-98. PubMed ID: 17432976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
    Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
    Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
    Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
    J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-beta modulates bone-associated cytokines and osteoclast precursor activity in multiple sclerosis patients.
    Weinstock-Guttman B; Hong J; Santos R; Tamaño-Blanco M; Badgett D; Patrick K; Baier M; Feichter J; Gallagher E; Garg N; Ramanathan M
    Mult Scler; 2006 Oct; 12(5):541-50. PubMed ID: 17086898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis-related molecules in blood in multiple sclerosis.
    Rinta S; Kuusisto H; Raunio M; Paalavuo R; Levula M; Lehtimäki T; Elovaara I
    J Neuroimmunol; 2008 Dec; 205(1-2):135-41. PubMed ID: 18963025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of TRAIL and its receptors on peripheral T-cells in type 1 diabetic patients.
    Salehi E; Vodjgani M; Massoud A; Keyhani A; Rajab A; Shafaghi B; Gheflati Z; Aboufazeli T
    Iran J Immunol; 2007 Dec; 4(4):197-205. PubMed ID: 18057577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary clinical measurement of the expression of TNF-related apoptosis inducing ligand in patients with ankylosing spondylitis.
    Zai-Xing Y; Yan L; Hao W; Ye Z; Chang L; Ren-Qian Z
    J Clin Lab Anal; 2008; 22(2):138-45. PubMed ID: 18348311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional characterization of a highly polymorphic region in the human TRAIL promoter in multiple sclerosis.
    Weber A; Wandinger KP; Mueller W; Aktas O; Wengert O; Grundström E; Ehrlich S; Windemuth C; Kuhlmann T; Wienker T; Brück W; Zipp F
    J Neuroimmunol; 2004 Apr; 149(1-2):195-201. PubMed ID: 15020080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS.
    Huang W-X ; Huang MP; Gomes MA; Hillert J
    Neurology; 2000 Oct; 55(7):928-34. PubMed ID: 11061246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis.
    Iłzecka J
    Acta Neurol Scand; 2008 May; 117(5):343-6. PubMed ID: 17995989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression and release of functional tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by T cells from lupus patients with active disease.
    Rus V; Zernetkina V; Puliaev R; Cudrici C; Mathai S; Via CS
    Clin Immunol; 2005 Oct; 117(1):48-56. PubMed ID: 15961346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
    Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
    Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL gene expression analysis in multiple sclerosis patients.
    Taheri M; Nemati S; Movafagh A; Saberi M; Mirfakhraie R; Eftekharian MM; Arsang-Jang S; Rezagholizadeh A; Sayad A
    Hum Antibodies; 2016 May; 24(1-2):33-8. PubMed ID: 27472871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
    Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
    Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E; Nakazawa M; Yoshinari M; Minami M
    J Virol; 2005 Jun; 79(12):7658-63. PubMed ID: 15919918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-related apoptosis-inducing ligand expression in patients with diabetic nephropathy.
    Chang WW; Liang W; Yao XM; Zhang L; Zhu LJ; Yan C; Jin YL; Yao YS
    J Renin Angiotensin Aldosterone Syst; 2018; 19(3):1470320318785744. PubMed ID: 29999450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.
    Moreno M; Sáenz-Cuesta M; Castilló J; Cantó E; Negrotto L; Vidal-Jordana A; Montalban X; Comabella M
    J Neuroimmunol; 2013 Oct; 263(1-2):152-4. PubMed ID: 23932896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.